| 2007 | Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma | HEPATOLOGY RESEARCH |
| 2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2009 | Recombinant interferon-Beta-1alpha plus ribavirin for the treatment of chronic HCV infection: a prospective, randomized, comparative pilot study
| GUT AND LIVER |
| 2016 | Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B | LIVER INTERNATIONAL |
| 2018 | Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2019 | Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
| PLOS ONE |
| 2015 | Reimbursement policies in the Asia-Pacific for chronic hepatitis B | HEPATOLOGY INTERNATIONAL |
| 2015 | Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography
| PLOS ONE |
| 2014 | Relationship Between Severity of Liver Dysfunction and the Relative Ratio of Liver to Aortic Enhancement (RE) on MRI Using Hepatocyte-Specific Contrast | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2007 | Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
| CANCER |
| 2018 | Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib | LIVER INTERNATIONAL |
| 2009 | Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir | ANTIVIRAL THERAPY |
| 2021 | Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2023 | Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2021 | Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
| 2014 | Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. | HEPATOLOGY |
| 2012 | Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement | DIGESTION |
| 2011 | Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2011 | Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | HEPATOLOGY |
| 2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2019 | Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2014 | Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving Entecavir | JOURNAL OF CLINICAL GASTROENTEROLOGY |
| 2011 | Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. | LANCET ONCOLOGY |
| 2016 | Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model | LIVER INTERNATIONAL |
| 2023 | Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease
| JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE |
| 2017 | Rituximab and hepatitis B reactivation in HBsAg-negative/ anti-HBc-positive kidney transplant recipients | NEPHROLOGY DIALYSIS TRANSPLANTATION |
| 2020 | RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection
| HEPATOLOGY |
| 2013 | Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism | ANZ JOURNAL OF SURGERY |
| 2007 | Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma | ONCOLOGY |
| 2018 | Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B | JOURNAL OF HEPATOLOGY |
| 2022 | Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B
| HEPATOLOGY COMMUNICATIONS |
| 2020 | Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial | LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2020 | Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2016 | Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011) | HEPATOLOGY |
| 2018 | Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
| GUT AND LIVER |
| 2021 | Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Self-Management and Associated Factors among Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study
| INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
| 2017 | Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer. | VIRUS RESEARCH |
| 2003 | Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production | GASTROENTEROLOGY |
| 2015 | Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2020 | Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2014 | Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
| PLOS ONE |
| 2022 | Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B | LIVER INTERNATIONAL |
| 2018 | Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection | JOURNAL OF VIRAL HEPATITIS |
| 2012 | Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study | INVESTIGATIONAL NEW DRUGS |
| 2023 | Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2009 | Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma. | JOURNAL OF MEDICAL VIROLOGY |
| 2012 | Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial
| YONSEI MEDICAL JOURNAL |
| 2014 | Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2019 | Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea
| ANNALS OF SURGICAL TREATMENT AND RESEARCH |
| 2022 | Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study
| HEPATOLOGY COMMUNICATIONS |
| 2023 | Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma | EUROPEAN JOURNAL OF CLINICAL INVESTIGATION |
| 2017 | Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis | HEPATOLOGY INTERNATIONAL |
| 2016 | Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database. | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2019 | Subclinical but significant liver fibrosis in patients with ANCA-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
| 2015 | Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
| PLOS ONE |
| 2014 | Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy | ANNALS OF SURGICAL ONCOLOGY |
